Medifast (MED) Current Assets (2010 - 2026)

Medifast has reported Current Assets for 17 years, with the latest figure at $202.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 5.1% year-over-year to $202.6 million; the trailing twelve-month figure through Mar 2026 stood at $202.6 million (down 5.1% YoY), and the FY2025 full-year result was $201.7 million, down 5.93% from the prior year.
• Current Assets for Q1 2026 stood at $202.6 million, roughly flat from $201.7 million in the prior quarter.
• The five-year high for Current Assets was $324.3 million in Q1 2022, with the low at $201.7 million in Q4 2025.
• Historically, Current Assets has averaged $226.0 million across 5 years, with a median of $224.0 million in 2023.
• Annual changes were most pronounced in 2022 — Current Assets advanced 15.04% — and 2023, when it retreated 28.97%.
• Medifast's Current Assets stood at $222.8 million in 2022, then rose by 0.56% to $224.0 million in 2023, then dropped by 4.3% to $214.4 million in 2024, then declined by 5.93% to $201.7 million in 2025, then rose by 0.47% to $202.6 million in 2026.
• The last three Current Assets figures came in at $202.6 million (Q1 2026), $201.7 million (Q4 2025), and $207.8 million (Q3 2025), per Business Quant data.